Weight loss injections, particularly glucagon-like peptide-1 (GLP-1) receptor agonists, can significantly impact gastrointestinal function
Hispanic females were at 49.4%
C 10.30 In adults with moderate hypertriglyceridemia (fasting or nonfasting triglycerides 175499 mg/dL), clinicians should address and treat lifestyle factors (obesity and metabolic syndrome), secondary factors (diabetes, chronic liver or kidney disease and/or nephrotic syndrome, hypothyroidism), and medications that raise triglycerides
Many individuals with excess weight have elevated liver enzymes due to fatty liver deposits
While the medication primarily impacts digestion and is known for digestive side effects such as nausea and diarrhea, theres limited evidence linking Mounjaro directly to significant changes in urine smell
According to FDA labeling, the precise mechanism for weight loss is not fully understood